Comparison between Veefin Solutions IPO and Vilin Bio Med IPO.
Veefin Solutions IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vilin Bio Med IPO is a SME Fixed Price proposed to list at NSE SME.
| Veefin Solutions IPO | Vilin Bio Med IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Shreni Shares Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Veefin Solutions IPO is up to ₹44.37 Cr whereas the issue size of the Vilin Bio Med IPO is up to ₹11.38 Cr. The final issue price of Veefin Solutions IPO is ₹82.00 per share and of Vilin Bio Med IPO is ₹30.00 per share.
| Veefin Solutions IPO | Vilin Bio Med IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹82.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 25,61,600 shares | 37,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹21.01 Cr | up to ₹11.38 Cr |
| OFS Issue Size | 28,49,600 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹23.37 Cr | up to ₹0.00 Cr |
| Issue Size Total | 54,11,200 shares | 37,92,000 shares |
| Issue Size Total (Amount) | up to ₹44.37 Cr | up to ₹11.38 Cr |
Veefin Solutions IPO opens on Jun 22, 2023, while Vilin Bio Med IPO opens on Jun 16, 2023. The closing date of Veefin Solutions IPO and Vilin Bio Med IPO is Jun 26, 2023, and Jun 21, 2023, respectively.
| Veefin Solutions IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 22, 2023 | Jun 16, 2023 |
| Issue Close | Jun 26, 2023 | Jun 21, 2023 |
| Basis Of Allotment (Tentative) | Jun 30, 2023 | Jun 26, 2023 |
| Initiation of Refunds (Tentative) | Jul 03, 2023 | Jun 27, 2023 |
| Credit of Share (Tentative) | Jul 04, 2023 | Jun 29, 2023 |
| Listing date (Tentative) | Jul 05, 2023 | Jun 30, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Veefin Solutions IPO P/E ratio is 41.41, as compared to Vilin Bio Med IPO P/E ratio of 24.59.
| Veefin Solutions IPO | Vilin Bio Med IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 56.26 | 91.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 39.84 | 64.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 41.41 | 24.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹173.74 Cr. | ₹41.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 13.42 | 14.76 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.32 | 8.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | 0.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.48 | ₹0.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 7.57 | 1.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Veefin Solutions IPO Retail Individual Investors (RII) are offered 27,05,600 shares while in Vilin Bio Med IPO retail investors are offered 27,05,600 shares. Qualified Institutional Buyers (QIB) are offered in Veefin Solutions IPO and in Vilin Bio Med IPO.
| Veefin Solutions IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,88,000 shares | 2,08,000 shares |
| QIB | ||
| NII | 27,05,600 shares | 18,96,000 shares |
| RII | 27,05,600 shares | 18,96,000 shares |
| Employee | ||
| Others | ||
| Total | 54,11,200 shares | 37,92,000 shares |
Veefin Solutions IPO subscribed 2.46x in total, whereas Vilin Bio Med IPO subscribed 2.80x.
| Veefin Solutions IPO | Vilin Bio Med IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.26x | 1.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.65x | 4.31x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.46x | 2.80x |
